Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treatment in Patients With Advanced Non-Squamous NSCLC

Clinical trial NCT03912389 · UNKNOWN

Trial details

NCT number: NCT03912389
Sponsor: Biocad
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Squamous Non-Small Cell Neoplasm of Lung

Start date: 2019-06-01
Primary completion: 2023-12-01
Enrollment: 292

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.